Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Decreased Iron Absorption in Obesity
NCT02745925Completed
- Sponsor
- ETH Zurich
- Start
- Apr 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ibuprofen in obesity (2 arms), sponsored by ETH Zurich. Primary endpoint: Fractional iron absorption at Day 45. Started Apr 2016; status: completed.
02
Drugs
ibuprofen
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02745925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745925.